Chinese herbal medicine for endometriosis

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Flower, Andrew ^a   Guanjian, L G J ^b   Little, P ^b   Liu, J P ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; PLACEBO;

BIOMEDICINE; CHINESE HERB; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; ENDOMETRIOSIS; ENDOMETRIUM ABLATION; FERTILITY; HUMAN; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 44949261032     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006568     Document Type: Review

References (37)

1. Abbott 2003 Abbott JA, Hawe J, Clayton RD, Garry R. The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with a 2-5 year follow up. Human Reproduction 2003;18(9):1922-7.
2. Abbott 2004 Abbott J, Hawe D, Hunter M, Holmes P, Garry F, Garry R. Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertility and Sterility 2004;82:878-84.
3. Anderson 2004 Anderson GL, Limacher M, Assaf AR, et al.Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 2004;291(14):1769-71.
4. Ballweg 2004 Ballweg ML. Impact of endometriosis on women's health: comparative historical data show that the earlier the onset, themore severe the disease. Best Practice & Research Clinical Obstetrics and Gynaecology 2004;18:201-18.
5. Biberoglu 1981 Biberoglu, et al.Dosage aspects of danazol therapy in endometriosis short and long term effectiveness. American Journal of Obstetrics and Gynecology 1981;139:645-54.
6. Bischoff 2004 Bischoff F, Simpson JL. Genetics of endometriosis: heritability and candidate genes. Best Practice & Research Clinical Obstetrics and Gynaecology 2004;18:219-32.
7. Cottreau 2003 Cottreau CM, Ness RB, Modugno F, Allen GO, Goodman MT. Endometriosis and its treatment with danazol or pupron in relation to ovarian cancer. Clinical Cancer Research 2003;9:5142-4.
8. Dmowski 1998 Dmowski W.P. Cohen M. Antigonadotrophin (danazol) in the treatment of endometriosis-evaluation of post treatment fertility and three year follow up data. American Journal of Obstetrics and Gynecology 1998;131:1978.
9. Eskenazi 1997 Eskenazi B, .Warner ML. Epidemiology of Endometriosis. Obstetrics and Gynecology Clinics of North America 1997;24:235-58.
10. Fedele 2004 Fedele L, Bianchi S, Zanconato G, Bettoni G, Gotsch F. Long term follow up after conservative surgery for rectovaginal endometriosis. American Jornal of Obstetrics and Gynecology 2004;190:1020-4.
11. Feste 1999 Feste JR, Winkel CA. Is the standard of care what we think it is?. Journal of the Society of Laparoendoscic Surgery 1999;3:331-4.
12. GISG 1996 The Gestrinone Italian Study Group (GISG). Gestrinone versus a gonadotrophin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double blind study. Fertlity and Sterility 1996;66:911-919.
13. Higgins 2003 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency inmeta-analyses. British Medical Journal 2003;327:557-60.
14. Huang 2006 Huang YH, Si TY. Advance of research on mechanism of Chinese medicine for the treatment of endometriosis. Hubei Journal of Traditional Chinese Medicine 2006;28(3):56-7.
15. Hughes 2004 Hughes E, Fedorkow D, Collins J, Vandekerchove P. Ovulation suppression for endometriosis. Cochrane Database of Systematic Reviews 2004, Issue 2.Art. No.: CD000155. DOI:10.1002/14651858.CD000155. pub2.
16. Koninckx 1996 Koninckx PR, Timmermans B, Meuleman C, Penninckkx F. Complications of CO2-laser endoscopic excision of deep endometriosis. Human Reproduction 1996;11(10):2263-8.
17. Lapp 2000 Lapp T. ACOG Issues Recommendations for the Management of Endometriosis. Sep 15, 2000. American Family Physician 2000;11(10):2263-8.
18. Lebovic 2001 Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertility & Sterility 2001;75:1-10.
19. Ling 1999 Ling FW. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Obstetrics and Gynecology 1999;37:51-8.
20. Low 1993 Low WY, Edelmann RJ, Sutton C. A pyschological profile of endometriosis patients in comparison to patients with pelvic pain of other origin. Journal Pyschosomatic Research 1993;37:111-6.
21. Malinak 1980 Malinak LR, Buttram Jr. VC, Elians, Simpson JL.Heritage aspects of endometriosis. II. Clinical characteristics of familial endometriosis. American Journal of Obstetrics and Gynecology 1980;137:332-337.
22. Moore 2004 Moore J, Kennedy S, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database of Systematic Reviews 2004, Issue 2.Art. No.: CD001019. DOI:10.1002/14651858. CD001019.pub2.
23. Noble 1997 Noble LS, Takayama K, Makagawa M, Putman JM, Johns DA, Hinshelwood MM, et al.Prostaglanding E2 stimulates aromatase expression in endometriosis-derived stromal cells. Journal of Clinical Endocrinology and Metabolism 1997;82:600-606.
24. Ohtake 2003 Ohtake F, Takayama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, et al.Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 2003;423:487-8.
25. Parazzini 2000 Parazzini F, Di Cintio E, Chatenould L, Moroni S, Ardovono I, Struzziero E, et al.Estroprogestin vs. gonadotrophin agonists plus estroprogest in in the treatment of endometriosis-related pelvic pain: a randomized trial. European Journal of Obstetrics, Gynecololgy and Reproductive Biology 2000;88:4-11.
26. Prentice 2004 Prentice A, Deary AJ, Goldbeck-Wood S, Farquhar C, Smith SK. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database of Systematic Reviews 2004, Issue 2.Art. No.: CD000346. DOI:10.1002/14651858.CD000346.pub2.
27. Sheng 1998 Sheng H, Shao JD, Morrow JD, Beauchamp RD, DuBois RN.Moderation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Research 1998;58:362-6.
28. Stenchever 2001 Stenchever M, Droegemueller W, Herbst A, Mishell D. Comprehensive Gynecology. Mosby, 2001.
29. Strauss 1992 Strauss B, Didzus A, Speidel H. A study of the psychosomatic aspects of endometriosis. Pyschotherapy Pyschosomatic Medical Pyschology 1992;42:242-52.
30. Sutton 1994 Sutton C, Ewen S, Whitelaw N, Haines P. Prospective , randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertility and Sterility 1994;62(4):696-700.
31. Vasilakis 1999 Vasilakis C, Jick H, del Mar Melero-Montes M. Risk of idiopathic venous thromboembolism in users of progestagens alone. The Lancet 1999;354:1610-1.
32. Vercellini 1993 Vercellini P, Bocciolone L, Vendola N, Colombo A, Marchini M, Crosignani PG. A gonadotrophin releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertility & Sterility 1993;60(1):75-79.
33. Wheeler 1983 Wheeler JM, Malinak LR. Recurrent endometriosis: incidence,management and prognosis. American Journal of Obstetric and Gynecology 1983;146(3):247-253.
34. Winkel 2003 Winkel CA. Evaluation and management of Women with Endometriosis. Obstetrics & Gynecology 2003;102:397-408.
35. Wu 1997 Wu.Y, Fischer. W. Practical Therapeutics of Traditional Chinese Medicine. Paradigm, 1997.
36. Xu 2004 Xu M, Si TY, Lao YR, Guo XF, Wen ZH, Lai SL. A literature review of clinical trials on Chinese medicine for endometriosis. Journal of Guangzhou University of Traditional Chinese Medicine 2004;21(5):399- 402.
37. Zondervan 2001 Zondervan KT, Yudkin PL, Vessey MP, Jenkinson CP, Dawes MG, Barlow DH, et al.Chronic pelvic pain in the community - symptoms, investigations, and diagnoses. American Journal of Obstetrics and Gynecology 2001;184:1149-55.